Corbus Pharmaceuticals Holdings, Inc. (CRBP): Price and Financial Metrics
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Today's Latest Price: $0.98 USD
Updated Oct 29 6:55pm
Add CRBP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CRBP Stock Summary
- For CRBP, its debt to operating expenses ratio is greater than that reported by merely 8.72% of US equities we're observing.
- Revenue growth over the past 12 months for Corbus Pharmaceuticals Holdings Inc comes in at -79.68%, a number that bests just 1.64% of the US stocks we're tracking.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CRBP comes in at -112.05% -- higher than that of just 4.01% of stocks in our set.
- Stocks that are quantitatively similar to CRBP, based on their financial statements, market capitalization, and price volatility, are NTLA, VBLT, VYGR, CTMX, and MORF.
- CRBP's SEC filings can be seen here. And to visit Corbus Pharmaceuticals Holdings Inc's official web site, go to www.corbuspharma.com.
CRBP Stock Price Chart Interactive Chart >
CRBP Price/Volume Stats
| Current price | $0.98 | 52-week high | $9.78 |
| Prev. close | $0.95 | 52-week low | $0.92 |
| Day low | $0.93 | Volume | 2,569,600 |
| Day high | $1.00 | Avg. volume | 2,367,880 |
| 50-day MA | $3.23 | Dividend yield | N/A |
| 200-day MA | $5.62 | Market Cap | 80.40M |
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Company Bio
Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. The company is based in Norwood, Massachusetts.
Loading social stream, please wait...